Response to Dr. Wald's Letter on Passive Smoke Exposure and Lung Cancer Risk
Author Information
Author(s): S.C. Darby, M.C. Pike
Primary Institution: ICRF Epidemiology Unit, Radcliffe Infirmary, Oxford; Department of Preventive Medicine, University of Southern California
Hypothesis
Is there a discrepancy between cotinine measurements in passive smokers and the estimated lung cancer risk from passive smoke exposure?
Conclusion
The study suggests that cotinine may not adequately measure non-smokers' exposure to harmful components of cigarette smoke.
Supporting Evidence
- The urinary cotinine levels of passive smokers were found to be significantly lower than those of active smokers.
- Only one of the 100 accepted non-smokers had a plasma cotinine value above 10 ng/ml.
- Excluding individuals who falsely claimed to be non-smokers was deemed justified.
Takeaway
The researchers think that measuring cotinine levels might not show how much harmful smoke non-smokers are really exposed to.
Methodology
The study compared urinary cotinine levels of passive smokers to those of active smokers.
Potential Biases
There may be risks of bias due to the exclusion of individuals who falsely claimed to be non-smokers.
Limitations
The study acknowledges uncertainties in measuring passive smoke exposure and the potential for misclassification of non-smokers.
Participant Demographics
Included 27 non-smokers with reported passive smoke exposure and 94 smokers.
Want to read the original?
Access the complete publication on the publisher's website